CM
ANIK icon

Caption Management’s Anika Therapeutics ANIK Stock Holding History

Caption Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-394,300
Closed -$16.1M – 1277
2021
Q1 		$16.1M Buy
394,300
+31,500
+9% +$1.19M 0.35% 55
2020
Q4 		$16.4M Sell
362,800
-178,400
-33% -$6.77M 0.37% 61
2020
Q3 		$19.2M Buy
541,200
+362,800
+203% +$13.1M 0.45% 35
2020
Q2 		$6.73M Buy
+178,400
New +$5.88M 0.22% 120
2019
Q3 		– Sell
-63,000
Closed -$2.56M – 694
2019
Q2 		$2.56M Buy
+63,000
New +$2.3M 0.13% 208

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Caption Management's ANIK Position: Q4 2019 in Review

Caption Management sold out of Anika Therapeutics (ANIK) in Q4 2019, closing a stake of 35,500 shares — an estimated $2.06M sold.

Caption Management first reported a position in ANIK in Q3 2019 and held it in 1 quarter. The position peaked at $1.95M in Q3 2019. 191 funds tracked by Wall St. Rank hold ANIK as of Q4 2019.

  • Caption Management reported no remaining Anika Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Caption Management sold 35,500 Anika Therapeutics shares in Q4 2019, an estimated $2.06M.
  • Caption Management first reported a position in Anika Therapeutics in Q3 2019 and held it in 1 quarter.
  • Caption Management's Anika Therapeutics position peaked at $1.95M in Q3 2019.
  • 191 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2019.

Based on Caption Management's 13F filing for Q4 2019, filed 13 Feb 2020.